abstract |
The invention relates to a drug composition for hyperphosphatemia and a preparation method of the drug composition. The drug composition, as chewable tablets, comprises 477-954g of lanthanum carbonate hydrate, 5-10g of polylactic acid, 500-1000g of dextrates, 20-40g of colloidal silicon dioxide and 10-20g of magnesium stearate. |